Target Name: Uridine phosphorylase
NCBI ID: P11318
Review Report on Uridine phosphorylase Target / Biomarker Content of Review Report on Uridine phosphorylase Target / Biomarker
Uridine phosphorylase
Other Name(s): None

Understanding Upl: Enzyme Involved in Uridine Metabolism and Protein Regulation

Uridine phosphorylase (Upl) is an enzyme involved in the metabolism of uridine, a crucial component of nucleic acids and proteins. Upl is a nonspecified subtype of the enzyme phosphorylase, which is a group of enzymes that catalyze the phosphorylation of amino acids. Upl is primarily found in the cytoplasm of eukaryotic cells and is responsible for the phosphorylation of uridine to uridine monophosphate (UMP).

UMP is a key intermediate step in the metabolism of uridine, which is both a precursor to nucleic acids and a catheterizing agent for various signaling pathways. In addition to its role in nucleic acid metabolism, Upl is also involved in the regulation of protein abundance and function.

The research on Upl has implications for the development of new therapeutics and diagnostic tools. One approach to targeting Upl is to inhibit its activity, which can be done with small molecules or antibodies that target the enzyme. In recent years, several studies have identified potential Upl inhibitors that have been shown to be effective in cell culture models of various diseases, including cancer.

Another approach to studying Upl is to use it as a biomarker.UMP levels have been shown to be elevated in various diseases, including cancer, and can be used as a diagnostic marker for some of these diseases. Researchers have also used Upl as a target for small molecule inhibitors and have shown that these inhibitors can selectively target Upl and inhibit its activity without affecting other enzyme activities.

In addition to its role in the metabolism of uridine, Upl is also involved in the regulation of protein synthesis and degradation. Upl promotes the synthesis of uridine from its precursor, 2-fluorouridine (2FU), and also regulates its degradation to uridine monophosphate. This regulation is critical for maintaining the homeostasis of uridine levels in the cell.

The role of Upl in the regulation of protein synthesis and degradation is still under investigation. Some studies have shown that Upl can inhibit the translation of mRNAs, while others have shown that it can enhance the degradation of mRNAs. More research is needed to fully understand the regulation of protein synthesis and degradation by Upl and to determine its potential as a therapeutic target.

In conclusion, Uridine phosphorylase (Upl) is an enzyme involved in the metabolism of uridine and the regulation of protein synthesis and degradation. Its role in these processes is critical for maintaining the homeostasis of uridine levels in the cell. The research on Upl has implications for the development of new therapeutics and diagnostic tools, as well as for understanding the regulation of protein synthesis and degradation. Further research is needed to fully understand the role of Upl in these processes and to determine its potential as a therapeutic target.

Protein Name: Uridine Phosphorylase (nonspecified Subtype)

The "Uridine phosphorylase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uridine phosphorylase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42 | USP43 | USP44 | USP45 | USP46 | USP46-DT | USP47 | USP48 | USP49 | USP5 | USP50 | USP51 | USP53 | USP54 | USP6 | USP6NL | USP6NL intronic transcript 1 (non-protein coding), transcript variant 1 | USP7 | USP8